BOSTON, MA / ACCESSWIRE / August 19, 2019 / Three of the nation’s leading African American cannabis medicine practitioners and business leaders are coming to Boston to talk about marijuana in one of the city’s communities most disproportionately harmed by the War on Drugs. ELEVATE Northeast’s Community Conversation event “Cannabis and Me” takes place Thursday, August 22 at the DeWitt Center in Roxbury, and features certified Cannabinoid Medicine specialist Dr. Rachel Knox, registered nurse and cannabis business operator Kebra Smith, and Hope Wiseman, the youngest African American woman in the United States to own a dispensary. Massachusetts Cannabis Control Commissioner Shaleen Title will deliver an opening keynote address, and ELEVATE director of community outreach, TaShonda Vincent-Lee, will moderate the panel discussion.
Click here to view the full multimedia interactive news release.
About ELEVATE Northeast Events and Education
ELEVATE Northeast Events and Education is a 501(c)(3) nonprofit organization created to support the regional cannabis industry’s need for workforce and community education, advocacy and networking in a professional and inviting atmosphere. And because cannabis businesses cannot succeed without inclusion of multiple perspectives, an educated community, and informed customer base, ELEVATE’s mission is to empower underrepresented populations to work and lead in the cannabis industry, and to empower our communities to be educated customers and responsible consumers. Learn more at elevatene.org.
CONTACT:
Beth Waterfall
team@elevatene.com
617-329-1370
Executive Director
SOURCE: Elevate Northeast
View source version on accesswire.com:
https://www.accesswire.com/556324/Cannabis-Doctor-Nurse-Dispensary-Owner-and-Commissioner-to-Discuss-Marijuana-at-Boston-Community-Center
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…